Table 5. Formulary Status of Agents for Type II HIT
| Agent | Formulary type | Daily Cost* |
|---|---|---|
| Lepirudin | Formulary | $590 |
| Argatroban | Formulary | $475 |
| Danaparoid | Nonformulary | $735 |
| Bivalirudin | Formulary-restricted to cardiac catheterization lab for patients who have a heparin allergy | -- |
*For 70 kg patient with normal renal and hepatic function
Click Here to Return to Article